CYRAMZA 500MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: ELI LILLY & COMPANY (INDIA) PVT LTD (ONCOLOGY DIV)

MRP: ₹248679.38

ELI LILLY & COMPANY (INDIA) PVT LTD (ONCOLOGY DIV): Cyramza 500MG Injection, 1 vial, salt ramucirumab 500mg. Its MRP stays at Rs 248,679.38 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 189,470. Group: VEGFR-2 monoclonal antibody (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion in hospital; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.